Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Multivariate piecewise exponential survival modeling. 26583951 Li Y, Panagiotou OA, Black A, Liao D, Wacholder S Biometrics 2015 PLCO
Physical activity and benign prostatic hyperplasia-related outcomes and nocturia. 25010403 Wolin KY, Grubb RL, Pakpahan R, Ragard L, Mabie J, Andriole GL, Sutcliffe S Med Sci Sports Exerc 2015 PLCO
Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial. 25985429 Guertin KA, Gu F, Wacholder S, Freedman ND, Panagiotou OA, Reyes-Guzman C, Caporaso NE PLoS ONE 2015 PLCO
Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial. 25835747 Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC J Gen Intern Med 2015 PLCO
Epidemiologic studies of estrogen metabolism and breast cancer. 25725255 Ziegler RG, Fuhrman BJ, Moore SC, Matthews CE Steroids 2015 PLCO
Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. 25533883 Alford SH, Rattan R, Buekers TE, Munkarah AR Cancer 2015 PLCO
Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 25225425 Zhou CK, Pfeiffer RM, Cleary SD, Hoffman HJ, Levine PH, Chu LW, Hsing AW, Cook MB J. Clin. Oncol. 2015 PLCO
Impact of family history on prostate cancer mortality in white men undergoing prostate specific antigen based screening. 25066872 Liss MA, Chen H, Hemal S, Krane S, Kane CJ, Xu J, Kader AK J. Urol. 2015 PLCO
Lung cancer screening: identifying the high risk cohort. 25984362 Marcus MW, Raji OY, Field JK J Thorac Dis 2015 PLCO
GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes. 26429724 Lee M, Williams KA, Hu Y, Andreas J, Patel SJ, Zhang S, Crawford NP Clin. Exp. Metastasis 2015 PLCO
Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial. 25982801 Liss MA, Xu J, Chen H, Kader AK Prostate 2015 PLCO
Variation of Prostate-specific Antigen Value in Men and Risk of High-grade Prostate Cancer: Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study. 25917734 Boniol M, Autier P, Perrin P, Boyle P Urology 2015 PLCO
Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 26269366 Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, Berndt SI Am. J. Clin. Nutr. 2015 PLCO
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 25156182 Weinstein SJ, Purdue MP, Smith-Warner SA, Mondul AM, Black A, Ahn J, Huang WY, Horst RL, Kopp W, Rager H, Ziegler RG, Albanes D Int. J. Cancer 2015 PLCO
Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. 25342387 Ananthakrishnan AN, Du M, Berndt SI, Brenner H, Caan BJ, Casey G, Chang-Claude J, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hou L, Hsu L, Jenkins MA, Kraft P, Ma J, Nan H, Newcomb PA, Ogino S, … Cancer Epidemiol. Biomarkers Prev. 2015 PLCO
Genetic variants of adiponectin and risk of colorectal cancer. 25431318 Song M, Gong J, Giovannucci EL, Berndt SI, Brenner H, Chang-Claude J, Curtis KR, Harrison TA, Hoffmeister M, Hsu L, Jiao S, Le Marchand L, Potter JD, Schoen RE, Seminara D, Slattery ML, White E, Wu K, Ogino S, Fuchs CS, Hunter DJ, Tworoger SS, Hu FB… Int. J. Cancer 2015 PLCO
A model to determine colorectal cancer risk using common genetic susceptibility loci. 25683114 Hsu L, Jeon J, Brenner H, Gruber SB, Schoen RE, Berndt SI, Chan AT, Chang-Claude J, Du M, Gong J, Harrison TA, Hayes RB, Hoffmeister M, Hutter CM, Lin Y, Nishihara R, Ogino S, Prentice RL, Schumacher FR, Seminara D, Slattery ML, Thomas DC, Thornquis… Gastroenterology 2015 PLCO
Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. 25781442 Nan H, Hutter CM, Lin Y, Jacobs EJ, Ulrich CM, White E, Baron JA, Berndt SI, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chang-Claude J, Chanock SJ, Cotterchio M, Duggan D, Figueiredo JC, Fuchs CS, Giovannucci EL, Gong J, Hai… JAMA 2015 PLCO
Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival. 25873087 Smith CG, Fisher D, Harris R, Maughan TS, Phipps AI, Richman S, Seymour M, Tomlinson I, Rosmarin D, Kerr D, Chan AT, Peters U, Newcomb PA, Idziaszczyk S, West H, Meade A, Kaplan R, Cheadle JP Clin. Cancer Res. 2015 PLCO
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. 25976416 Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Dugg… Cancer Epidemiol. Biomarkers Prev. 2015 PLCO